{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:27:19Z","timestamp":1764350839837},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sporadic late onset nemaline myopathy is a rare, progressive muscle disease, presenting in adulthood, mainly affecting proximal limb and bulbar muscles. Muscle biopsies show characteristic nemaline rods. The putative mechanism is considered immune-related. Other manifestations aside from neuromuscular symptoms have not been described previously.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present a case with atypical sporadic late onset nemaline myopathy (SLONM) of a non-HIV, non-MGUS subtype, where skin manifestations preceded neuromuscular symptoms, and a residual thymus with the histology of thymic follicular hyperplasia was detected during the diagnostic workup. Thorough dermatological investigations could not explain the skin presentations. Muscle biopsy revealed variation in fiber diameter, ragged-red and COX-negative fibers associated with discrete fibrosis. Electron microscopy detected atrophic muscle fibres with disorganization of the myofibrils, nemaline rods and abnormal mitochondria. Single-fiber EMG suggested signs of a neuromuscular transmission defect, EMG showed signs of myopathy. Analyses of antibodies associated with myasthenia gravis were negative. The patient showed improvement after intravenous immunoglobulin treatment regarding both the skin and the muscle symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our case highlights the heterogeneity of SLONM with its varied spectrum of presentation. A unique combination of dermatological symptoms and SLONM could be seen with skin lesions as primary presenting symptoms. An association can be considered between the different manifestations, presumably based on immune etiology, where immunosuppressive therapy has been beneficial.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03283-7","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T10:01:57Z","timestamp":1686909717000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Anirban","family":"Nandy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Tankisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Bruun","family":"Kr\u00f8ig\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiken Glud","family":"Dalager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Skov","family":"Hvidbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Daa","family":"Schr\u00f8der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabella","family":"Ob\u00e1l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"3283_CR1","doi-asserted-by":"publisher","unstructured":"Engel WK, Wanko T, Fenichel GM. Nemaline myopathy, a second case. Archives of Neurology 1964 Jul;11 doi: https:\/\/doi.org\/10.1001\/archneur.1964.00460190026003.","DOI":"10.1001\/archneur.1964.00460190026003"},{"key":"3283_CR2","doi-asserted-by":"publisher","unstructured":"Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P et al. Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases. Orphanet J. Rare Dis. 2017 May 11;12(1) doi: https:\/\/doi.org\/10.1186\/s13023-017-0640-2.","DOI":"10.1186\/s13023-017-0640-2"},{"key":"3283_CR3","doi-asserted-by":"publisher","unstructured":"Naddaf E, Milone M, Kansagra A, Buadi F, Kourelis T. Sporadic late-onset nemaline myopathy clinical spectrum, survival, and treatment outcomes, Neurol 2019 Jul 16;93(3) doi: https:\/\/doi.org\/10.1212\/WNL.0000000000007777.","DOI":"10.1212\/WNL.0000000000007777"},{"key":"3283_CR4","doi-asserted-by":"publisher","unstructured":"Tanboon J, Uruha A, Arahata Y, Dittmayer C, Schweizer L, Goebel HH, et al. Inflammatory features in sporadic late onset nemaline myopathy are independent from monoclonal gammopathy. Brain Pathol. 2021 May;31(3). https:\/\/doi.org\/10.1111\/bpa.12962.","DOI":"10.1111\/bpa.12962"},{"key":"3283_CR5","doi-asserted-by":"publisher","unstructured":"Milone M, Katz A, Amato AA, Soderland CA, Segarceanu M, Young NP, et al. Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy. Muscle Nerve. 2010 Feb;41(2). https:\/\/doi.org\/10.1002\/mus.21504.","DOI":"10.1002\/mus.21504"},{"key":"3283_CR6","doi-asserted-by":"publisher","unstructured":"De Ridder W, De Jonghe P, Straub V, Baets J. High prevalence of sporadic late-onset nemaline myopathy in a cohort of whole-exome sequencing negative myopathy patients. Neuromusc Disord. 2021 Nov;31(11). https:\/\/doi.org\/10.1016\/j.nmd.2021.04.010.","DOI":"10.1016\/j.nmd.2021.04.010"},{"key":"3283_CR7","doi-asserted-by":"publisher","unstructured":"Chahin N, Selcen D, Engel AG. Sporadic late onset nemaline myopathy Neurology 2005 oct 25;65(8) doi: https:\/\/doi.org\/10.1212\/01.wnl.0000180362.90078.dc.","DOI":"10.1212\/01.wnl.0000180362.90078.dc"},{"key":"3283_CR8","doi-asserted-by":"publisher","unstructured":"Jungbluth H, Treves S, Zorzato F, Sarkozy A, Ochala J, Sewry C, et al. Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction. Nat Rev Neurol Mar. 2018;14(3). https:\/\/doi.org\/10.1038\/nrneurol.2017.191.","DOI":"10.1038\/nrneurol.2017.191"},{"key":"3283_CR9","doi-asserted-by":"publisher","unstructured":"Naddaf E, Dasari S, Selcen D, Charlesworth MC, Johnson KL, Mauermann ML, Kourelis T. Proteomic profiling of sporadic late-onset nemaline myopathy. Ann Clin Transl Neurol. 2022 Mar;9(3). https:\/\/doi.org\/10.1002\/acn3.51527.","DOI":"10.1002\/acn3.51527"},{"key":"3283_CR10","doi-asserted-by":"publisher","unstructured":"Monforte M, Primiano G, Silvestri G, Mirabella M, Luigetti M, Cuccagna C, et al. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort. J Neurol. 2018 Mar;265(3). https:\/\/doi.org\/10.1007\/s00415-018-8741-y.","DOI":"10.1007\/s00415-018-8741-y"},{"key":"3283_CR11","doi-asserted-by":"publisher","unstructured":"Finsterer J, Wakil S. Abnormalities of skin and cutaneous Appendages in Neuromuscular Disorders, Pediatr Neurol. 2015 Oct;53(4) doi:https:\/\/doi.org\/10.1016\/j.pediatrneurol. 2015.03.005.","DOI":"10.1016\/j.pediatrneurol"},{"key":"3283_CR12","doi-asserted-by":"publisher","unstructured":"Hindocha A, Klimiuk P, Roberts M, Pal P, Evangelista T, Lochm\u00fcller H, Chinoy H. Co-presentation of adult-onset systemic lupus erythematosus and nemaline myopathy. Rheumatology (Oxford) 2017 Nov 1;56(11) doi:https:\/\/doi.org\/10.1093\/rheumatology\/kex252.","DOI":"10.1093\/rheumatology\/kex252"},{"key":"3283_CR13","doi-asserted-by":"publisher","unstructured":"Vogel C, Manwani P, Cornford ME, Heinze ER. Nemaline myopathy in newly diagnosed systemic lupus erythematosus and Sj\u00f6gren\u00b4s overlap syndrome complicated by macrophage activation syndrome. BMC Rheumatol 2022 Mar 15;6 (1) doi: https:\/\/doi.org\/10.1186\/s41927-022-00246-2.","DOI":"10.1186\/s41927-022-00246-2"},{"key":"3283_CR14","doi-asserted-by":"publisher","unstructured":"Cao L, Wang Y, Liu X, Hu Y, Li N, Qiu G et al. Adult-onset Nemaline Myopathy coexisting with Myasthenia Gravis, Medicine (Baltimore). 2016 Jan;95(4) doi: https:\/\/doi.org\/10.1097\/MD.0000000000002527.","DOI":"10.1097\/MD.0000000000002527"},{"key":"3283_CR15","doi-asserted-by":"publisher","unstructured":"Kanatani M, Adachi T, Sakata R, Watanabe Y, Hanajima R. A case of sporadic late-onset nemaline myopathy associated with myasthenia gravis positive for anti-titin antibody and anti-Kv1.4 antibody. Rinsho Shinkeigaku 2020 Jul 31;60(7) doi: https:\/\/doi.org\/10.5692\/clinicalneurol.60.cn-001427.","DOI":"10.5692\/clinicalneurol.60.cn-001427"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03283-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03283-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03283-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T10:02:38Z","timestamp":1686909758000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03283-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03283-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical publication"}},{"value":"Written informed consent was obtained from the patient regarding publication of data and pictures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}